OS Therapies Files Definitive Additional Materials
Ticker: OSTX · Form: DEFA14A · Filed: Aug 25, 2025 · CIK: 1795091
| Field | Detail |
|---|---|
| Company | Os Therapies Inc (OSTX) |
| Form Type | DEFA14A |
| Filed Date | Aug 25, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, sec-filing, pharmaceutical
TL;DR
OS Therapies dropped more proxy docs, check 'em.
AI Summary
OS Therapies Inc. filed definitive additional materials on August 25, 2025, related to its proxy statement. The filing is under Schedule 14A, indicating it concerns shareholder matters. The company, previously known as OS THERAPIES Inc., is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing provides shareholders with crucial supplementary information for upcoming decisions, impacting their voting rights and the company's future direction.
Risk Assessment
Risk Level: low — This filing is a routine administrative submission of additional proxy materials, not indicating any immediate financial or operational risks.
Key Players & Entities
- OS Therapies Inc. (company) — Registrant
- OS THERAPIES Inc (company) — Former Company Name
- August 25, 2025 (date) — Filing Date
FAQ
What type of SEC filing is this?
This is a DEFA14A filing, which is a Definitive Additional Materials filing under Schedule 14A.
Who is the filer?
The filer is OS Therapies Inc.
When was this filing made?
The filing was made on August 25, 2025.
What is the company's industry?
The company is in the Pharmaceutical Preparations sector, with SIC code 2834.
What was the company's former name?
The company's former name was OS THERAPIES Inc., with a name change date of November 25, 2019.
Filing Stats: 127 words · 1 min read · ~1 pages · Grade level 16.2 · Accepted 2025-08-25 17:15:04
Filing Documents
- ea0253947-defa14a_ostherap.htm (DEFA14A) — 9KB
- image_001.jpg (GRAPHIC) — 487KB
- 0002077096-25-000060.txt ( ) — 681KB
From the Filing
ADDITIONAL MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to § 240.14a-12 OS THERAPIES INCORPORATED (Name of Registrant as Specified in its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of Filing Fee (Check all boxes that apply): No fee required Fee paid previously with preliminary materials Fee computed in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11